{
  "hypothesis": "h239",
  "title": "Antifungal Drug Repurposing Analysis",
  "outcome": "INVALIDATED",
  "summary": {
    "total_predictions": 183,
    "gt_hits": 52,
    "overall_precision": 28.4,
    "original_hypothesis": "Antifungals have anti-inflammatory properties for repurposing",
    "actual_finding": "High precision comes from CORRECT fungal indications, not repurposing"
  },
  "top_drugs": {
    "Fluconazole": {
      "precision": 80.0,
      "count": 10,
      "reason": "Established fungal indications"
    },
    "Itraconazole": {
      "precision": 69.2,
      "count": 13,
      "reason": "Established fungal indications"
    },
    "Miconazole": {
      "precision": 60.0,
      "count": 5,
      "reason": "Established fungal indications"
    },
    "Ketoconazole": {
      "precision": 47.1,
      "count": 17,
      "reason": "Established fungal indications"
    },
    "Amphotericin B": {
      "precision": 42.3,
      "count": 26,
      "reason": "Gold standard for invasive fungal"
    }
  },
  "disease_analysis": {
    "fungal_infections": "~80% of predictions (aspergillosis, cryptococcosis, histoplasmosis, etc.)",
    "cancer_prophylaxis": "~10% (oropharynx cancer = fungal prophylaxis in immunocompromised)",
    "incorrect": "~10% (tuberous sclerosis, hypothyroidism = FALSE POSITIVES)",
    "autoimmune": "0% precision - WRONG predictions"
  },
  "key_findings": [
    "Antifungal high precision is from CORRECT fungal-disease relationships, not repurposing",
    "Model correctly learns: Fluconazole \u2192 cryptococcosis, Amphotericin B \u2192 invasive aspergillosis",
    "Seborrheic dermatitis hits are valid: caused by Malassezia yeast",
    "Oropharynx cancer hits: fungal prophylaxis context, not anti-cancer repurposing",
    "Anti-inflammatory repurposing hypothesis is REFUTED",
    "Autoimmune predictions (0% precision) are FALSE POSITIVES"
  ],
  "conclusion": "Original hypothesis INVALIDATED. The model correctly predicts antifungal-fungal relationships but does NOT identify anti-inflammatory repurposing opportunities."
}